Cigna Investments’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-6,971
| Closed | -$1.28M | – | 775 |
|
|
2021
Q2 | $1.28M | Sell |
6,971
-906
| -12% | -$166K | 0.09% | 191 |
|
|
2021
Q1 | $1.21M | Buy |
7,877
+237
| +3% | +$36.3K | 0.08% | 224 |
|
|
2020
Q4 | $1.19M | Buy |
7,640
+519
| +7% | +$81.1K | 0.09% | 200 |
|
|
2020
Q3 | $814K | Sell |
7,121
-33
| -0.5% | -$3.77K | 0.08% | 233 |
|
|
2020
Q2 | $804K | Buy |
7,154
+928
| +15% | +$104K | 0.08% | 252 |
|
|
2020
Q1 | $559K | Buy |
6,226
+400
| +7% | +$35.9K | 0.07% | 297 |
|
|
2019
Q4 | $578K | Sell |
5,826
-755
| -11% | -$74.9K | 0.06% | 349 |
|
|
2019
Q3 | $694K | Buy |
6,581
+280
| +4% | +$29.5K | 0.07% | 316 |
|
|
2019
Q2 | $713K | Sell |
6,301
-81
| -1% | -$9.17K | 0.08% | 295 |
|
|
2019
Q1 | $863K | Sell |
6,382
-166
| -3% | -$22.4K | 0.1% | 256 |
|
|
2018
Q4 | $638K | Sell |
6,548
-17
| -0.3% | -$1.66K | 0.05% | 267 |
|
|
2018
Q3 | $736K | Sell |
6,565
-500
| -7% | -$56.1K | 0.06% | 254 |
|
|
2018
Q2 | $877K | Sell |
7,065
-1,034
| -13% | -$128K | 0.06% | 271 |
|
|
2018
Q1 | $902K | Sell |
8,099
-2,631
| -25% | -$293K | 0.06% | 275 |
|
|
2017
Q4 | $1.28M | Sell |
10,730
-368
| -3% | -$44K | 0.08% | 193 |
|
|
2017
Q3 | $1.56M | Sell |
11,098
-52
| -0.5% | -$7.3K | 0.1% | 146 |
|
|
2017
Q2 | $1.36M | Buy |
11,150
+1,936
| +21% | +$236K | 0.09% | 177 |
|
|
2017
Q1 | $1.12M | Buy |
9,214
+1,003
| +12% | +$122K | 0.08% | 245 |
|
|
2016
Q4 | $1.01M | Buy |
+8,211
| New | +$1.01M | 0.11% | 237 |
|